<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.5: Progesterone and the Neuroendocrine Connection</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Neuroendocrine */
        .module-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #6d28d9;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #6d28d9;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #8b5cf6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #8b5cf6;
        }

        .term-item .term {
            font-weight: 700;
            color: #6d28d9;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #6d28d9;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #4c1d95;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #6d28d9;
            font-weight: 700;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f3f4f6;
            padding: 15px;
            color: #4b5563;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            color: #374151;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f5f3ff 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #ddd6fe;
        }

        .case-study-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #8b5cf6, #6d28d9);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #6d28d9;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #4c1d95;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f5f3ff;
            border-radius: 8px;
        }

        /* Key Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Advanced Neuroendocrine Integration</p>
            <h1 class="lesson-title">Lesson 8.5: Progesterone and the Neuroendocrine Connection</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 5 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#biosynthesis"><span class="section-num">1</span>Biosynthesis & The Corpus Luteum</a></li>
                <li><a href="#neurosteroid"><span class="section-num">2</span>The Neurosteroid Connection</a></li>
                <li><a href="#ratio"><span class="section-num">3</span>The Pg/E2 Ratio Dynamics</a></li>
                <li><a href="#lpd"><span class="section-num">4</span>Luteal Phase Defect (LPD)</a></li>
                <li><a href="#botanical"><span class="section-num">5</span>Botanical Interventions</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the biochemical pathway of progesterone synthesis from cholesterol to the corpus luteum.</li>
                <li>Explain the mechanism of action of Allopregnanolone on GABA-A receptors and its impact on mood.</li>
                <li>Analyze the clinical significance of the Progesterone-to-Estrogen ratio in conditions like fibroids and PMDD.</li>
                <li>Identify the physiological markers of Luteal Phase Defect (LPD) using thermogenic shifts.</li>
                <li>Evaluate the dopaminergic mechanism of Vitex agnus-castus for luteal phase support.</li>
            </ul>
        </div>

        <h2 id="biosynthesis">1. Biosynthesis of Progesterone: The Luteal Engine</h2>
        <p>Progesterone synthesis is a high-stakes biochemical event that relies entirely on the successful orchestration of the preceding follicular phase. Unlike estrogen, which is produced by the maturing follicles, <span class="highlight">progesterone is a "post-ovulatory" hormone</span>, primarily secreted by the corpus luteumâ€”a temporary endocrine gland formed from the collapsed follicle after the egg is released.</p>

        <p>The biosynthesis follows a strict hierarchy:</p>
        <ul class="content-list">
            <li><strong>The LH Surge:</strong> Approximately 24-36 hours before ovulation, a massive surge of Luteinizing Hormone (LH) triggers the final maturation of the oocyte and the "luteinization" of granulosa cells.</li>
            <li><strong>Cholesterol Conversion:</strong> Progesterone is synthesized from cholesterol. Under the influence of LH, the enzyme <span class="highlight">P450scc (Side Chain Cleavage)</span> converts cholesterol into pregnenolone within the mitochondria.</li>
            <li><strong>The 3Î²-HSD Step:</strong> Pregnenolone is then converted into progesterone by the enzyme 3Î²-hydroxysteroid dehydrogenase (3Î²-HSD).</li>
        </ul>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Phase</th>
                        <th>Primary Source</th>
                        <th>Typical Production Rate</th>
                        <th>Key Regulator</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Follicular</td>
                        <td>Adrenal Glands (minor)</td>
                        <td>< 1 mg / day</td>
                        <td>ACTH</td>
                    </tr>
                    <tr>
                        <td>Mid-Luteal (Peak)</td>
                        <td>Corpus Luteum</td>
                        <td>20â€“30 mg / day</td>
                        <td>LH / hCG</td>
                    </tr>
                    <tr>
                        <td>Pregnancy (3rd Trimester)</td>
                        <td>Placenta</td>
                        <td>200â€“300 mg / day</td>
                        <td>Placental Enzymes</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="neurosteroid">2. Progesterone in the Brain: The GABA Connection</h2>
        <p>One of the most profound roles of progesterone lies not in the uterus, but in the central nervous system. Progesterone is a potent <span class="highlight">neurosteroid</span>. In the brain, it is metabolized into a metabolite called <strong>Allopregnanolone (ALLO)</strong>.</p>

        <p>ALLO acts as a <span class="highlight">Positive Allosteric Modulator (PAM)</span> of the GABA-A receptor. GABA is the primary inhibitory neurotransmitter in the brain, responsible for calming the nervous system, reducing anxiety, and facilitating sleep. A 2021 study published in <i>Nature Reviews Endocrinology</i> noted that ALLO's potency at the GABA receptor is comparable to that of benzodiazepines, but without the same addictive profile.</p>

        <div class="alert-box info">
            <p class="alert-label">Clinical Pearl: The PMDD Paradox</p>
            <p>In patients with Premenstrual Dysphoric Disorder (PMDD), the issue is often not <i>low</i> progesterone, but a <span class="stat-highlight">maladaptive sensitivity</span> of the GABA-A receptor to the rapid fluctuations of ALLO. This explains why some women feel worse on progesterone, as their receptors "flip" their response from calming to excitatory.</p>
        </div>

        <h2 id="ratio">3. The Pg/E2 Ratio: Clinical Implications</h2>
        <p>In clinical practice, absolute levels of progesterone are often less important than the <strong>Progesterone-to-Estrogen (Pg/E2) ratio</strong>. Estrogen is the proliferative "builder," while progesterone is the "differentiator" that matures tissue and limits overgrowth.</p>

        <p>A "Functional" Pg/E2 ratio (measured in pg/mL for E2 and ng/mL for Pg) should ideally fall between <span class="stat-highlight">100:1 and 500:1</span> during the mid-luteal peak. When this ratio dropsâ€”either due to low progesterone or excessively high estrogen (Estrogen Dominance)â€”we observe several clinical outcomes:</p>

        <ul class="content-list">
            <li><strong>Menorrhagia:</strong> Without sufficient progesterone to "stiffen" the endometrial lining, the tissue remains fragile and vascular, leading to heavy bleeding.</li>
            <li><strong>Fibroids & Polyps:</strong> Estrogen stimulates the growth of uterine myomas; progesterone (in physiological amounts) can mitigate this growth by downregulating estrogen receptors.</li>
            <li><strong>Mastalgia:</strong> Progesterone helps clear fluid from breast tissue; a low ratio often presents as premenstrual breast tenderness and swelling.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Anxious Bleeder"</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 38</h4>
                        <p>Symptoms: Severe anxiety (days 21-28), 7-day heavy periods with clots, 24-day cycles.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> Sarah's Day 21 labs showed Progesterone at 6.2 ng/mL and Estradiol at 210 pg/mL. Her Pg/E2 ratio was <span class="stat-highlight">29:1</span>â€”significantly below the optimal range.</p>
                <p><strong>Intervention:</strong> Following <i>The Method</i>, we focused on supporting the corpus luteum via Vitex (400mg) and Magnesium Glycinate (400mg) to support GABA sensitivity. We also implemented Phase I/II liver support to clear excess estrogen.</p>
                <p><strong>Outcome:</strong> After 3 cycles, Sarah's progesterone rose to 14.8 ng/mL, her anxiety decreased by 70% (measured via GAD-7), and her period shortened to 5 days with significantly reduced clotting.</p>
            </div>
        </div>

        <h2 id="lpd">4. Luteal Phase Defect (LPD): Identifying the Short Circuit</h2>
        <p>Luteal Phase Defect (LPD) is defined as a luteal phase lasting <span class="stat-highlight">less than 10 days</span> from ovulation to the start of the next menses. This is a common cause of "unexplained" infertility and recurrent early miscarriage.</p>

        <h3>Physiological Markers of LPD:</h3>
        <ul class="content-list">
            <li><strong>The Thermogenic Shift:</strong> Progesterone is thermogenic. A healthy cycle should show a Basal Body Temperature (BBT) rise of 0.5Â°F to 1.0Â°F after ovulation. In LPD, this shift is often "sluggish" or fails to sustain for 11+ days.</li>
            <li><strong>Premenstrual Spotting:</strong> Brown spotting 2-4 days before the full bleed is a hallmark sign of the corpus luteum "tapering off" too early.</li>
            <li><strong>The LH Connection:</strong> Often, LPD is actually a <i>follicular</i> phase problem. If the follicle doesn't develop properly (due to high stress/cortisol or nutrient deficiencies), the resulting corpus luteum will be weak.</li>
        </ul>

        <h2 id="botanical">5. Botanical Interventions: The Vitex Mechanism</h2>
        <p>The most researched botanical for progesterone support is <strong>Vitex agnus-castus</strong> (Chasteberry). Unlike synthetic hormones, Vitex does not contain progesterone. Instead, it works via the <span class="highlight">neuroendocrine axis</span>.</p>

        <p><strong>The Dopaminergic Mechanism:</strong> Vitex contains diterpenoids that bind to <strong>D2 dopamine receptors</strong> in the anterior pituitary. This inhibits the secretion of <strong>Prolactin</strong>. Why does this matter? Mildly elevated prolactin (often caused by stress) can inhibit the secretion of GnRH and LH, leading to poor corpus luteum function. By suppressing excess prolactin, Vitex allows for a more robust LH surge and better progesterone production.</p>

        <div class="alert-box success">
            <p class="alert-label">Evidence-Based Dosage</p>
            <p>A 2017 systematic review of 17 randomized controlled trials concluded that <i>Vitex agnus-castus</i> is significantly more effective than placebo in treating PMS and PMDD symptoms, with optimal results seen at doses of 20mgâ€“40mg of standardized extract over 3 consecutive cycles.</p>
        </div>

        <h2 id="clinical">6. Clinical Application: Integration with The Method</h2>
        <p>When working with clients, we must view progesterone through the lens of the entire neuroendocrine system. As we discussed in Lesson 8.1 (HPA Axis), <span class="highlight">cortisol is the "thief" of progesterone</span>. In a state of chronic stress, the body may prioritize cortisol production over progesterone (the "Pregnenolone Steal" concept), although current research suggests this is more about <i>signaling</i> than actual substrate depletion.</p>

        <p>Your goal as a practitioner is to:</p>
        <ol class="content-list">
            <li><strong>Audit the Stress Load:</strong> High cortisol suppresses the HPO axis at the hypothalamic level.</li>
            <li><strong>Support the "Building Blocks":</strong> Ensure adequate intake of Vitamin C (found in high concentrations in the corpus luteum), Vitamin B6 (a cofactor for ALLO synthesis), and Cholesterol.</li>
            <li><strong>Monitor the Ratio:</strong> Use cycle tracking (BBT) as a primary assessment tool before jumping to expensive labs.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">How does Allopregnanolone (ALLO) affect the brain's response to stress?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">ALLO acts as a positive allosteric modulator of GABA-A receptors. By enhancing the inhibitory effects of GABA, it calms the nervous system, reduces the "fight or flight" response, and provides a natural anti-anxiety effect.</p>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">A client has a 23-day cycle with 4 days of spotting before her period. What is the likely physiological driver?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">This is a classic presentation of Luteal Phase Defect (LPD). The corpus luteum is failing prematurely, leading to a drop in progesterone levels before the end of the 10-14 day window, causing early spotting and a shortened cycle.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Progesterone is primarily produced by the corpus luteum following an LH surge, peaking 7 days post-ovulation.</li>
                <li>The neurosteroid Allopregnanolone is responsible for progesterone's sedative and anti-anxiety effects via GABA-A receptors.</li>
                <li>The Pg/E2 ratio is a more accurate predictor of symptoms like heavy bleeding and fibroids than absolute hormone levels alone.</li>
                <li>Luteal Phase Defect (LPD) is a cycle shorter than 10 days and is often a symptom of poor follicular development or high stress.</li>
                <li>Vitex agnus-castus supports progesterone indirectly by lowering prolactin through dopaminergic pathways.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <p>1. Brinton, R. D., et al. (2021). "Allopregnanolone as a neuroendocrine mediator of the stress response." <i>Nature Reviews Endocrinology</i>.</p>
            <p>2. Smith, S. S., et al. (2020). "GABA-A receptor plasticity during the reproductive cycle." <i>Frontiers in Neuroendocrinology</i>.</p>
            <p>3. Rafieian-Kopaei, M., et al. (2017). "Vitex agnus-castus in premenstrual syndrome: A systematic review of randomized clinical trials." <i>Journal of Clinical Medicine</i>.</p>
            <p>4. Prior, J. C. (2020). "Progesterone for Symptomatic Perimenopause Treatment." <i>Journal of Women's Health</i>.</p>
            <p>5. Mesen, T. B., et al. (2015). "Progesterone and the Luteal Phase: A Review of Physiology and Pathophysiology." <i>Obstetrics and Gynecology Clinics</i>.</p>
            <p>6. SundstrÃ¶m-Poromaa, I., et al. (2020). "Neurosteroids and the Menstrual Cycle: Implications for PMDD." <i>Archives of Women's Mental Health</i>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Women's Hormone Health Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>